Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilance
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Friday, November 22, 2024
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilance
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilance
Scientific Writing
Other
About us
Search
LATEST ARTICLES
Latest Pharma-News
First generics of Gilenya approved by FDA for the treatment of relapsing forms of multiple sclerosis (MS) in adult patients
admin
-
December 6, 2019
0
Latest Pharma-News
U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Alecto’s investigational therapeutic AL001, for the treatment of patients with...
admin
-
December 6, 2019
0
Latest Pharma-News
U.S. FDA approved BMS Breakthrough Therapy Designation for ORENCIA® (abatacept) just to help in Preventing Acute Graft-Versus-Host Disease, a Potentially Life-Threatening Complication...
admin
-
December 6, 2019
0
Latest Pharma-News
U.S. Food and Drug Administration (FDA) approved Investigational New Drug (IND) application for Dominant Negative PD-1 “Armored” Next Generation CAR-T Cell Therapy
admin
-
December 5, 2019
0
Latest Pharma-News
Ardelyx’s kidney disease drug succeeded in regulating elevated blood phosphate levels in patients with chronic kidney disease (CKD)
admin
-
December 5, 2019
0
Latest Pharma-News
United States Food and Drug Administration (USFDA) approved Bortezomib for Injection (IV) 3.5 mg/vial for the treatment of cancers in adult patients
admin
-
December 5, 2019
0
Latest Pharma-News
U.S. Food and Drug Administration (FDA) approved Regenerative Medicine Advanced Therapy (RMAT) designation from the for ADP-A2M4 for the treatment of synovial...
admin
-
December 5, 2019
0
Latest Pharma-News
Immunomedics Resubmits Biologics License Application to FDA for the treatment of metastatic triple-negative breast cancer (mTNBC)
admin
-
December 4, 2019
0
Latest Pharma-News
The U.S. Food and Drug Administration (FDA) has cleared the Atreca’s Investigational New Drug (IND) application for first-in-human Phase 1b clinical trial of ATRC-101...
admin
-
December 4, 2019
0
Latest Pharma-News
OSE Immunotherapeutics Announces Positive Results from first-in-human dose-escalation, randomized, double-blind, placebo-controlled Phase 1 trial of Anti-IL-7 Receptor Antagonist OSE-127
admin
-
December 4, 2019
0
Latest Pharma-News
AstraZeneca divests rights Seroquel (quetiapine fumarate immediate release) and Seroquel XR (quetiapine fumarate extended release) in the US and Canada to Cheplapharm Arzneimittel GmbH...
admin
-
December 4, 2019
0
Latest Pharma-News
Co-Diagnostics Gets “Indian FDA” Approval for Infectious Disease Testing (in vitro diagnostic assays)in One of the World’s Biggest Markets
admin
-
December 4, 2019
0
1
...
149
150
151
...
156
Page 150 of 156
Other
What is Decentralized clinical trials?:Benefits and challenges of implementing DCT
September 23, 2024
Navigating the Job Interview: How to Answer the Question, “Why Are You Changing Jobs?”
September 16, 2023
Big Data Analytics: New Possibilities In The Pharmaceutical Industry
November 19, 2021
Causes, Symptoms And Treatment Of Mesothelioma
October 4, 2021
Load more